Surgery, Abdominal Transplant Surgery
-
-
Administers Grant
-
A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF QPI-1002 FOR PREVENTION OF DELAYED GRAFT FUNCTION IN RECIPIENTS OF A DONATION AFTER BRAIN DEATH OLDER DONOR KIDNEY TRANSPLANT (ReGIFT)
-
A Phase 2a Randomized open label study to assess Bleselumab
-
A Phase 3 prospective, randomized, multicenter, open-label, controlled trial to assess the efficacy and safety of cellular immunotherapy with MDR-101 for induction of immune tolerance in recipients of HLA-Matched, living donor kidney transplants
-
A Prospective, Open-Label, Long-Term Safety and Efficacy of Teduglutide
-
A multi-center, randomized double-blind, three-arm, parallel-group trial to assess the efficacy and safety of NTRA-9620 in infants with short bowel syndrome (SBS) following surgical resection
-
A multicenter randomized, controlled trial to compare the efficacy of ex-vivo normothermic machine perfusion with static cold storage in human liver transplantation
-
A multicenter, double-blind, randomized, placebo-controlled trial to evaluate the efficacy and safety of apraglutide in adult subjects with short bowel syndrome and intestinal failure (SBS-IF)
-
A randomized, parallel-group, double-blind, placebo-controlled, multi-center study of eculizumab for the prevention of delayed graft function after kidney transplantation in adult subjects at increased risk of delayed graft function
-
ASTS Presidential Student Mentor Grant
-
ASTS Presidential Student Mentor Grant
-
ASTS-Alexion Presidential Student Mentor Grant
-
Acoustic based plasmapheresis to prevent antibody-mediated organ transplant
-
Alexion Sponsored Research Agreement
-
Allo Vir ALVR105
-
AlloVir P105-401 Registry
-
American Journal of Transplantation
-
BMS-EnList
-
CD57+CD4+ T cells in Belatacept-resistant Renal Allograft Rejection
-
Clinical use of Teduglutide in children with short bowel syndrome: a multi-center post-marketing evaluation
-
Creating a Multidimensional Data Architecture to Improve Equity in Organ Transplantation
-
Developing clinically relevant immunosuppressive regimen for pig to rhesus kidney transplantation using transgenic pigs
-
EP394.A: Real-Time Flow Cytometry For ADAPT Development Budget
-
EP394.B: Real-Time Flow Cytometry For ADAPT
-
EP396: HLA Reporter Cell Lines for Desensitization Trials
-
EP397: Memory B Cell Pilot Assays For ADAPT ITN089ST / ADAPT
-
EVALUATION OF PATIENT OUTCOMES FROM THE KIDNEY ALLOGRAFT OUTCOMES ALLOSURE REGISTRY (KOAR)
-
EVALUATION OF PATIENT OUTCOMES FROM THE KIDNEY ALLOGRAFT OUTCOMES ALLOSURE REGISTRY (KOAR) AGREEMENT
-
Effects of storage method on intestinal allograft immune profile and viability
-
Evaluation of Acute Rejection Rates in de novo Renal Transplant Recipients Following
Thymoglobulin Induction, CNI-free, Nulojix (belatacept) -based Immunosuppression
-
Gene therapy of discarded human kidney grafts during 48 hours ex-vivo machine perfusion
-
IM101-823 - Abatacept for treatment of recurrent or de novo autoimmune hepatitis
-
IMAGINE
-
ITN089ST (ADAPT) - Measuring Allospecific Impact Of Belatacept/Carfilzomib Desensitization
-
ITN089ST Measuring Allospecific Impact of Belatacept/Carfilzomib Desensitization Protocol Chair
-
ITN336 Immune Tolerance Network
-
Impact of Visual Education on Adolescent Liver Transplant Patients' Transition Readiness
-
International Intestinal Failure Registry - Pro00100987
-
LET vs VGCV for Prevention of CMV disease in Kidney Transplant Recipients
-
Living Donor Kidney Transplant: Establishing the Phenotype of an Equitable Program
-
Lung Transplant Plasmapheresis (PLEX)/Belatacept/Carfilzomib Protocol for Treatment of Antibody Mediated Rejection (AMR) and Desensitization
-
Measuring the Impact of Allosensitization on Xenotransplantation
-
Molecular Assessment and Profiling of Liver transplant rEcipients: The MAPLE Study - Pro00108291
-
Novartis - CCFZ533A2202 - Liver Transplant Patients
-
Novartis - CFZ533A2201 Study for Kidney Transplant Patients
-
OCS Liver Registry
-
Paragonix LIVERguard
-
Pharmacodynamic Study Investigating Two Doses of Teduglutide in Pediatric Subjects Through 17
-
Phase2 Prospective, Multi-center, Open-label, Controlled Trial to Assess the Safety and Efficacy
of Cellular Immunotherapy with MDR-103 for Induction of Mixed Chimerism and Immune
Tolerance in Past Recipients of HLA Zero-mismatch, Living Donor Kid
-
Preventing allograft rejection but not tolerance by blockade of the lymphocyte store-operated calcium channel
-
Prevention of Homograft Induced Cardiac Allograft Vasculopathy in Pediatric Heart Transplantation
-
Prevention of Homograft Induced Cardiac Allograft Vasculopathy in Pediatric Heart Transplantation
-
Proposal for preliminary proof of concept studies with Plasmin in transplantation
-
Prospective, Randomized, Controlled, Multicenter, Multi-National, Pivotal, Clinical Investigation Evaluating the Safety and Efficacy of HEMOBLASTTM Bellows in Cardiothoracic, Abdominal, and Orthopedic Lower Extremity Surgeries
-
Protara- THRIVE Study - Pro00108876
-
Sample Collection for Prospera Enhancement by Detecting dd-cfDNA Levels (PEDAL Study)
-
Short Bowel Syndrome Registry
-
T Cell Maturation and the Nexus of Viral- and Allo-Immunity
-
Talaris Therapeutics - FCR001A2301 FREEDOM-1 Study
-
Targeting complement C2 in a sensitized rat cardiac allograft model
-
Targeting complement C3 to prevent acute antibody-mediated rejection for a deceased-donor kidney transplant in sensitized recipients
-
Targeting complement activation steps in antibody-mediated rejection
-
Targeting mitochondrial dysfunction and damage-associated molecular patterns to improve the function of high risk grafts in liver transplantation
-
Targeting the B Cell Response to Treat Antibody-Mediated Rejection
-
The Delivery of AAV Vector to Liver Allograft using Machine Perfusion System
-
The Risks and Opporunities of Homeostatic Repopulation
-
Transplant Genomics - TruGraf testing
-
Transplant Tolerance in Non-Human Primates
-
Transplant Tolerance in Non-Human Primates
-
Transplant Tolerance in Non-Human Primates
-
TruGraf Long-term Clinical Outcomes Study - Pro00108037
-
Use of Sirtuin-1 Activators to Mitigate Ischemia-Reperfusion Injury after Liver Transplantation
-
Visiting Research Fellowship